Loading clinical trials...

Treatment of the Anemia of Myelodysplastic Syndromes by the Association of Epoetin Beta and All Trans Retinoic Acid | Clinical Trials | Clareo Health

Back to clinical trial search

UNKNOWNPhase 2NCT00437450

Treatment of the Anemia of Myelodysplastic Syndromes by the Association of Epoetin Beta and All Trans Retinoic Acid

The purpose of this study is * To evaluate the efficacy of association of Erythropoetin (Neorecormon) and ATRA in patients with low risk myelodysplastic syndromes * To evaluate the tolerance of this ...

Lead sponsor: Groupe Francophone des Myelodysplasies•24 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

Active Not RecruitingPhase 2

A Phase 2a Study of HT-6184 in Subjects With IPSS-R Very Low, Low or Intermediate Risk MDS and Anemia

NCT07052006 · Myelodysplastic Syndrome, Anemia in Myelodysplastic Syndromes

TERMINATEDPhase 1/2

A Study of TP-0184 to Treat Anemia in Adults With IPSS-R Low or Intermediate Risk MDS

NCT04623996 · Anemia in Myelodysplastic Syndromes

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 18, 2009Terms

Trial snapshot

StatusUNKNOWN

PhasePHASE2

Enrollment99

Start dateOct 2004

Last updatedNov 18, 2009

Condition

Anemia in Myelodysplastic Syndromes

Locations shown

CHU d'Amiens

Amiens

CHU d'Angers

Angers

CHU d'Avignon

Avignon

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 18, 2009Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions